HER2-positive circulating tumor cells in breast cancer - Wikidata - wikimedia - TriplyDB

HER2-positive circulating tumor cells in breast cancer

HER2-positive circulating tumor cells in breast cancer

http://www.wikidata.org/entity/Q33802925

about

Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Circulating cancer stem cells: the importance to select Minimal residual disease and circulating tumor cells in breast cancer Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack EMT and dissemination precede pancreatic tumor formation Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices.Early dissemination seeds metastasis in breast cancer.Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry.Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs International study on inter-reader variability for circulating tumor cells in breast cancer The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Circulating tumor cells in non-metastatic triple-negative breast cancer.Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker.The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.Circulating Tumor Cells Detected by RT-PCR for CK-20 before Surgery Indicate Worse Prognostic Impact in Triple-Negative and HER2 Subtype Breast Cancer.Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.A novel approach for next-generation sequencing of circulating tumor cells A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation Biomarkers characterization of circulating tumour cells in breast cancer patients Considerations in the development of circulating tumor cell technology for clinical use Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer.Tumor cell dissemination: emerging biological insights from animal models and cancer patients.Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer.Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.

P2860

Q24594878-F480AD44-794F-4D91-80A5-43A8982F1E4F Q26748850-DFBE16B7-6258-4B0A-B52F-04597C1A8EB1 Q26778924-17BCC16E-9C29-4B5D-A9BA-5B97ED650DC1 Q27010152-C04C5C01-C4B5-45AE-A01C-EDA683222148 Q28067549-FB2274FA-E429-4E62-938D-76A88A64B2A0 Q29615854-39146627-0528-4496-97A1-742D23376266 Q30365308-30865B5C-0706-4398-9828-1197EA585A13 Q33562263-B76CD39F-3676-44EE-9DD2-0D28F267A7DA Q33618285-35CA172D-4702-43BD-A194-05C57318BE8B Q33626833-D463BB6E-944A-4BB7-9009-599A529AABCC Q33688469-18B3DE5E-CAF2-4DEE-8E3B-202EEB2A7428 Q33738688-D29C0CEA-4E81-407E-AC74-CFF8A29FA423 Q33769034-70D4C8E1-A35C-4197-BAA5-DE9248F13F9C Q33820233-CB438AB5-229B-4987-A5C2-D044A5B1C997 Q34111867-5B6BD47B-F528-4C01-9B63-90E3CD0291B6 Q34396921-36F4CC80-1EB0-4D47-BFDF-D45CFB6EA5CB Q34687153-436CE474-DF01-4225-AC62-34B41D973EED Q34717298-713C00D6-71F0-470B-BBED-18C4BF5764B9 Q35124176-0C26D179-B30E-49F8-94CC-994E8FF94E43 Q35538013-820ABCC5-4ADD-435C-B593-AB6DE1BF90B5 Q35619770-E05AD59E-4361-4ACB-B11C-B0FA4144CA39 Q35665814-0D8610AC-4FEB-4E0F-A68E-D2B6399B2672 Q35735913-0B7F2FC0-4DCF-4649-B098-4E43B2BE2782 Q35749122-FA6DAB9E-354C-4B38-BA0B-771C9E322B8B Q35784738-3A59D3FD-2B15-42ED-A622-C519C2AD8D31 Q35866927-B1C646CF-49C0-4C9A-B0F6-EF30C00EFC45 Q36085254-0351E4E1-37CB-4482-842B-C5182D2145B8 Q36085375-C86F51D5-95C7-4B05-8825-D6B3C68C7813 Q36088952-5820A113-39A4-447A-AE4B-058D414E8104 Q36206190-4B3709BF-3944-4561-A9A1-0B629E623425 Q36245346-113ABFB7-76DC-46CA-AA4E-9D7207613A9F Q36338628-FB6592F7-E0CB-4AE2-96B7-341F2AFA005E Q36525788-F6FAB9D3-C125-4C43-8AB3-C0E79DE70733 Q36747333-57714419-55A0-48CC-87F7-D23A2220BE7A Q36804888-6EC653F7-74C8-4A73-9BDE-8350F59EAFCB Q36887350-8AB8486B-0037-461E-A93B-4277ED390923 Q36959162-AB478B18-DFC1-4A34-8F08-B27B036D3AF2 Q37352090-53B8BCEC-E80D-4BC2-B18A-F9FEDB74176A Q37352624-CFBDD203-6A04-4B25-A5AE-1EE0E13B9DA8 Q37626062-3E2FFB99-C7A3-4379-8C91-3727E4B0CBF1

P2860

HER2-positive circulating tumor cells in breast cancer

http://www.wikidata.org/entity/Q33802925

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

HER2-positive circulating tumor cells in breast cancer

@ast

HER2-positive circulating tumor cells in breast cancer

@en

type

label

HER2-positive circulating tumor cells in breast cancer

@ast

HER2-positive circulating tumor cells in breast cancer

@en

prefLabel

HER2-positive circulating tumor cells in breast cancer

@ast

HER2-positive circulating tumor cells in breast cancer

@en

P1433

Q33802925-A5C69E29-8F85-4974-9320-51AD6EFD2651

P1476

Q33802925-2DB69547-2B75-45AB-A4BA-5790B4B4D109

P2093

Q33802925-0D35FD3C-7740-4136-B43F-9C151EBDE4B2

Q33802925-32241FCD-29E5-48B4-9D4A-53A76D6EAC7D

Q33802925-363DBC4C-EAA8-4661-9B68-62C32C312BE2

Q33802925-436C56BE-9AD3-4DDB-B362-80A6D93ED209

Q33802925-5329A805-55B4-413D-917F-B7F79D9270D0

Q33802925-5643A759-C399-4F26-B81E-B17E6A0599CB

Q33802925-6D5CADF3-30C6-4250-BA59-363636ADD430

Q33802925-70A784D1-EFC9-4934-B1D0-8348F98DF620

Q33802925-7E66189C-3779-4EBD-8E8C-741D2EC7FDE2

Q33802925-88321120-50CA-472F-9040-AF66C9D82B2A

P2860

Q33802925-0383774D-9C5C-4D13-ADE2-A5C95A957097

Q33802925-08110A05-505F-4F31-B3FA-D4B27BEC6EAE

Q33802925-0E4EAEE3-9DED-4D71-A828-8EEB47079BF4

Q33802925-11745D45-7BAC-4E3D-BEB2-FC4048899FDD

Q33802925-1CDF1AEA-DF94-43DB-89FE-FC41976F821D

Q33802925-24A7AFA3-D4CF-4DA9-9DE6-10A5A05B7396

Q33802925-275F7488-B078-4F60-9D6B-EDB5D7CB79FC

Q33802925-421F5EEE-C268-434E-9539-D2482F5A66CA

Q33802925-53DB6319-7439-4A4B-9510-8643D946F573

Q33802925-542681F4-3206-4BE6-9DE3-3B917CA665DC

P304

Q33802925-7E7C6577-FC84-4233-9B10-2B2D586D97BC

P31

Q33802925-D6CA8A68-1450-44FD-B301-729369C6B7FD

P356

Q33802925-F06AB10A-6E95-4062-8DF7-12EA13CEE5FC

P407

Q33802925-4F12A914-C84F-4843-A4E1-0088E0DB4DC4

P433

Q33802925-54DA31C6-0529-409D-A604-65542F5B6DF7

P478

Q33802925-72B62E30-1701-40DE-A1AF-E5E3D80DD572

P50

Q33802925-5110EDC7-33CE-4213-AAAC-CDED7DE927DA

P577

Q33802925-08917B16-881C-4052-98E7-ACE176ADCABA

P5875

Q33802925-382A0C91-9991-490D-9444-B009E26E06F5

P698

Q33802925-E678B9A1-20FE-46D3-827A-238B61677C6C

P932

Q33802925-19CB69B5-E34A-4B4B-B179-ED1B13E1D2AF

P356

JOURNAL.PONE.0015624

P1433

P1476

HER2-positive circulating tumor cells in breast cancer

@en

P2093

Birgit Carly

http://www.w3.org/2001/XMLSchema#string

Carmen Criscitiello

http://www.w3.org/2001/XMLSchema#string

Carole Chaboteaux

http://www.w3.org/2001/XMLSchema#string

Christos Sotiriou

http://www.w3.org/2001/XMLSchema#string

Denis Larsimont

http://www.w3.org/2001/XMLSchema#string

Fabienne Liebens

http://www.w3.org/2001/XMLSchema#string

Françoise Rothé

http://www.w3.org/2001/XMLSchema#string

Frédéric Buxant

http://www.w3.org/2001/XMLSchema#string

Ghizlane Rouas

http://www.w3.org/2001/XMLSchema#string

Isabelle Veys

http://www.w3.org/2001/XMLSchema#string

P2860

HER-2 gene amplification can be acquired as breast cancer progresses

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Systemic spread is an early step in breast cancer

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Cell analysis system based on immunomagnetic cell selection and alignment followed by immunofluorescent analysis using compact disk technologies.

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

P304

e15624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0015624

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Michiels

P577

2011-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49783002

http://www.w3.org/2001/XMLSchema#string

P698

21264346

http://www.w3.org/2001/XMLSchema#string

P932

3018524

http://www.w3.org/2001/XMLSchema#string